Perfil
Benoit Bouche is currently the Chief Executive Officer at Pacific Biomarkers, Inc., the President, Chief Executive Officer & Director at Nexelis Laboratories Canada, Inc., and the Operating Partner at Ampersand Management LLC.
He previously served as the President & Chief Executive Officer at NEOMED-LABS, Inc. and as an Analyst at Puilaetco in 2001.
Cargos activos de Benoit Bouche
| Empresas | Cargo | Inicio |
|---|---|---|
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Director Ejecutivo | - |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Director Ejecutivo | 01/01/2017 |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Inversor de Capital Privado | 01/04/2022 |
Antiguos cargos conocidos de Benoit Bouche.
| Empresas | Cargo | Fin |
|---|---|---|
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 05/12/2001 |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
- Bolsa de valores
- Insiders
- Benoit Bouche
















